Novavax, Inc. (NVAX) stock slides, “Hold” rating reaffirmed by Cantor Fitzgerald Analysts

Novavax, Inc. (NASDAQ: NVAX) shares fell in early trading today on lower trade volume than normal after a number of analysts weighed in on the investing value of the stock and reiterated thier respective ratings.

Meanwhile, U.S. stocks opened significantly lower in early trading. The Dow Jones Industrial Average was 58 points lower, or 0.29% to 19895, the S&P 500 fell 7 points, or 0.28% to 2268, while the Nasdaq dropped 22 points, or 0.38% to 5542.

Analysts at Cantor Fitzgerald reiterated a Hold rating on shares of Novavax, Inc. (NASDAQ: NVAX) in a reserach note to investors, making it one of the more actively watched stocks on Wall Street. Cantor Fitzgerald currently has a rating of Hold on the stock. As a means of comparison, a number of other analysts have issued reports on the stock recently, and Novavax, Inc. has earned a consensus one-year price target of $3.29, higher than the opening price of $1.35. Novavax, Inc. stock has a 52-week high of $8.49. Typically, after analysts give a “reiterated rating” report on a stock, they will later issue recurring revisions, usually followed by a price target change.

Yesterday Novavax, Inc. (NASDAQ: NVAX) shares last traded at $1.32, a dip of $0.03 from the previous closing price. Opening at $1.35, they ranged from $1.31 and $1.35 throughout the day.

Novavax, Inc. (NASDAQ: NVAX) now has a market cap of 357.97M.

Novavax, Inc. (NASDAQ: NVAX) Average Daily Trading Volume

912,341 shares traded hands yesterday, 50 percent lower than normal, out of a total float 267,011,000. lower than normal. Look for trading volume to pick up in the coming days as momentum traders often use swings in trading volume to identify heavy volume accumulation or distribution by institutional investors.

However, a single day of heavy buy side trading is not enough to assert a trend. As such, market traders will continue to watch for institutional sponsorship as a signal that financial institutions are moving forward.

Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.

Institutional investors such as these retain substantial teams of analysts that research thousands of stocks. Thus, watching their interests is a good way to ensure you are buying the right stocks.

Novavax, Inc. (NASDAQ: NVAX) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By tracking the activity of these professional investors—and the moving averages they affect—it allows for traders to make more effective decisions on trades.

Trades for Novavax, Inc. (NASDAQ: NVAX) have ranged from $1.16 – 8.49, and the stock now has a 50-day MA of $1.33 and 200-day MA of $4.06. Today’s last price is 84.45%% lower than the 52 week high of $8.49.

Indeed, earnings growth is among the most important things to look at in regards to stock investing and, accordingly, investors seek companies that have increased their earnings by at least 25% for 3 consecutive years.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *